Category: Spinal

Neuralstem aims to treat paralysis in spinal injury stem cell trial

August 27, 2010 by MassDevice staff

Neuralstem Inc. (AMEX:CUR) asked the Food & Drug Administration for permission to begin a clinical trial of a chronic spinal injury treatment using stem cells.

The Rockville, Md.-based company's Phase I clinical safety trial would employ its adult stem cell technology with cells derived from spinal cords to treat 16 patients with American Spinal Injury Assn. Grade A level of impairment, or complete paralysis, one to two years after the injury that caused their condition.

Exactech adds to spine line with acquisition

August 27, 2010 by MassDevice staff

Exactech Inc. (NSDQ:EXAC) bought several spinal reconstruction products from VertiFlex Inc.

The Gainsville, Fla.-based company develops biologic materials and restoration products for the hip, knee, shoulder and spine. The acquisition allows the company to expand its minimally invasive spinal surgery product offering.

AxioMed pulls in $14.5 million to fund U.S. spinal disc study

July 22, 2010 by MedCity News

By Mary Vanac

AxioMed Spine Corp. raised $14.5 million in Series D funding to help the company finish enrolling patients for a pivotal U.S. clinical study of its lumbar disc replacement and earn CE Mark approval for its cervical disc in Europe.

The Garfield Heights, Ohio-based developer of next-generation spinal disc replacements said it raised the money in two tranches from new and existing investors.

Newly appointed DeMane out at Lanx

July 1, 2010 by MassDevice staff

Michael DeMane quit his new job as chairman and CEO of Lanx Inc.

The former Medtronic Inc. (NYSE:MDT) COO took over the top spot at the privately held Bloomfield, Colo.-based spinal surgery device maker June 21.

The company said he will assist the company as a consultant while co-founder Dr. Jeffrey Thramann will remain chairman of the board.

A Lanx spokesperson said DeMane changed his mind about taking the job, but declined to further elaborate.

Anulex reels in another $18 million

June 4, 2010 by MedCity News

By Thomas Lee

Anulex Technologies Inc. of Minnetonka, Minn., raised $18 million in a Series E financing round and plans to raise at least $2 million more, according to CFO David Noel.

That brings Anulex’s total haul to about $75 million since 2003, including a $3.8 million sale debt and options offering in March.

Stryker launches iVAS spine fracture treatment

April 13, 2010 by MassDevice staff

Less than a month after winning 510(k) clearance from the Food & Drug Administration, Stryker Corp.'s (NYSE:SYK) iVAS inflatable vertebral augmentation system is on the market.

Anulex Technologies pulls in $4 million

March 25, 2010 by MedCity News

By Brandon Glenn

Fresh from the launch of its next-generation spinal tissue repair device, Anulex Technologies Inc. raised $3.8 million iun a debt and options sale to 11 investors, according to a regulatory filing.